GLAUKOS Corp (GKOS) stock
GKOSNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 7/30215% above fair value
$243.25−1.63 (-0.67%)
Close on Nov 17, 2026Market cap $14.40BP/E –Yield –
Glaukos operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Glaukos's operating cash flow for the twelve months ending Sep 30, 2026 was $47.71M. For fiscal 2025 it was -$14.79M. The highest annual figure on record is $26.09M in fiscal 2017.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$14.79M | – |
| FY2024 | Dec 31, 2024 | -$61.32M | – |
| FY2023 | Dec 31, 2023 | -$57.76M | – |
| FY2022 | Dec 31, 2022 | -$33.08M | -233.9% |
| FY2021 | Dec 31, 2021 | $24.71M | – |
| FY2020 | Dec 31, 2020 | -$22.99M | – |
| FY2019 | Dec 31, 2019 | -$369.00K | -102.0% |
| FY2018 | Dec 31, 2018 | $18.86M | -27.7% |
| FY2017 | Dec 31, 2017 | $26.09M | +112.0% |
| FY2016 | Dec 31, 2016 | $12.31M | – |
| FY2015 | Dec 31, 2015 | -$2.19M | – |
| FY2014 | Dec 31, 2014 | -$7.11M | – |
| FY2013 | Dec 31, 2013 | -$13.31M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $38.57M | – |
| Q2 FY2026 | Jun 30, 2026 | $14.82M | +112.4% |
| Q1 FY2026 | Mar 31, 2026 | -$12.53M | – |
| Q4 FY2025 | Dec 31, 2025 | $6.84M | +1249.7% |
| Q3 FY2025 | Sep 30, 2025 | -$10.09M | – |
| Q2 FY2025 | Jun 30, 2025 | $6.98M | – |
| Q1 FY2025 | Mar 31, 2025 | -$18.52M | – |
| Q4 FY2024 | Dec 31, 2024 | $507.00K | – |
| Q3 FY2024 | Sep 30, 2024 | -$9.59M | – |
| Q2 FY2024 | Jun 30, 2024 | -$18.37M | – |
| Q1 FY2024 | Mar 31, 2024 | -$33.87M | – |
| Q4 FY2023 | Dec 31, 2023 | -$10.67M | – |
| Q3 FY2023 | Sep 30, 2023 | -$8.17M | – |
| Q2 FY2023 | Jun 30, 2023 | -$8.16M | – |
| Q1 FY2023 | Mar 31, 2023 | -$30.76M | -414.8% |
| Q4 FY2022 | Dec 31, 2022 | -$4.14M | – |
| Q3 FY2022 | Sep 30, 2022 | -$26.52M | -249.0% |
| Q2 FY2022 | Jun 30, 2022 | -$12.21M | -265.1% |
| Q1 FY2022 | Mar 31, 2022 | $9.77M | +133.9% |
| Q4 FY2021 | Dec 31, 2021 | -$4.65M | -143.9% |
| Q3 FY2021 | Sep 30, 2021 | $17.79M | – |
| Q2 FY2021 | Jun 30, 2021 | $7.39M | – |
| Q1 FY2021 | Mar 31, 2021 | $4.18M | – |
| Q4 FY2020 | Dec 31, 2020 | $10.60M | – |
| Q3 FY2020 | Sep 30, 2020 | -$9.57M | – |
| Q2 FY2020 | Jun 30, 2020 | -$10.92M | -265.4% |
| Q1 FY2020 | Mar 31, 2020 | -$13.10M | -6397.6% |
| Q4 FY2019 | Dec 31, 2019 | -$4.19M | -124.5% |
| Q3 FY2019 | Sep 30, 2019 | -$2.99M | -168.5% |
| Q2 FY2019 | Jun 30, 2019 | $6.60M | +72.6% |
| Q1 FY2019 | Mar 31, 2019 | $208.00K | – |
| Q4 FY2018 | Dec 31, 2018 | $17.13M | +37.4% |
| Q3 FY2018 | Sep 30, 2018 | $4.36M | -37.6% |
| Q2 FY2018 | Jun 30, 2018 | $3.83M | -11.3% |
| Q1 FY2018 | Mar 31, 2018 | -$6.45M | -377.4% |
| Q4 FY2017 | Dec 31, 2017 | $12.46M | +280.2% |
| Q3 FY2017 | Sep 30, 2017 | $6.99M | – |
| Q2 FY2017 | Jun 30, 2017 | $4.31M | – |
| Q1 FY2017 | Mar 31, 2017 | $2.33M | – |
| Q4 FY2016 | Dec 31, 2016 | $3.28M | – |
See a number that looks wrong?